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To elucidate the molecular mechanism underlying the toxicity of the Fusarium mycotoxin nivalenol, we investigated
the involvement of ryanodine receptor 1 (RyR1), an intracellular calcium ion channel, in nivalenol-induced cytotoxicity in
human promyelocytic leukemia HL60 cells by using an RyR1-specific inhibitor dantrolene. Cell proliferation and cy-
tokine levels were investigated after 24-h treatment with the chemicals. Nivalenol markedly hindered cell proliferation,
while dantrolene retarded moderately. If RyR1 is not concerned with the nivalenol signal-transduction pathway(s), dan-
trolene should magnify the inhibitory effect of nivalenol. However, dantrolene did not strengthen the effect of nivalenol,
therefore, RyR1 might play a role in the nivalenol-associated retardation of cell proliferation. Nivalenol significantly elic-
ited interleukin (IL)-8 secretion, while dantrolene did not. Dantrolene substantially attenuated the effect of nivalenol, in-
dicating that RyR1 is important for nivalenol-induced IL-8 secretion. Nivalenol reduced monocyte chemotactic protein
(MCP)-1 secretion, while dantrolene decreased moderately. Dantrolene clearly alleviated the effect of nivalenol, indicat-
ing that RyR1 mediates the nivalenol-induced inhibition of MCP-1 secretion. Taken together the above results, the in-
volvement of RyR1 in nivalenol-induced toxicity in HL60 cells was deduced.
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Introduction
A variety of Fusarium fungi produce a number of
different mycotoxins of the class of trichothecenes and
some other mycotoxins (zearalenone and fumonisins).
More than 60 trichothecene mycotoxins are known; niva-
lenol is one such trichothecene. Trichothecene mycotox-
ins are extremely toxic to rapidly dividing cells, including
leukocytes, and alimentary toxic aleukia, a type of leuco-
penia, is one of the leading symptoms of trichothecene
toxicosis1). We have previously reported that nivalenol
hinders cell proliferation2), induces apoptosis3) and inter
leukin-8 (IL-8)2) secretion, and decreases monocyte che-
motactic protein-1 (MCP-1)4) secretion in the human pro-
myelocytic leukemia cell line HL60. In addition, intracel-
lular calcium ion2, 3) and stress-activated mitogen-activated
protein (MAP) kinases5) occupy crucial positions in the
exertion of nivalenol-associated toxicity.
Since intracellular calcium ion contributes to the niva
lenol-induced cytotoxicity2, 3), we hypothesized that cal-
cium ion is discharged from the intracellular calcium ion
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stores into the cytoplasm by the action of nivalenol. Ry-
anodine receptors6)—RyR1, RyR2, and RyR3—are local-
ized in the endoplasmic reticulum (ER) membrane and are
specialized intracellular calcium ion channels for the rapid
and extensive release of calcium ion. Upon external
stimulation, RyRs mediate the release of calcium ion from
the ER calcium store to the cytoplasm. RyRs are mainly
expressed in excitable cells and play pivotal roles in mus-
cle contraction and various neuronal activities. In this
study, to elucidate the molecular mechanism underlying
the toxicity of nivalenol, we focused on RyR1 and investi-
gated the effects of dantrolene, an RyR1-specific inhibi-
tor7), on nivalenol-induced cytotoxicity in HL60 cells.
Materials and Methods
Chemicals and cells
Nivalenol was purchased from Sigma-Aldrich (St.
Louis, MO, USA) and dissolved in dimethyl sulfoxide.
Dantrolene was purchased from Merck KGaA (Darmstadt,
Germany) and dissolved in water. Cell proliferation
ELISA, BrdU (Colorimetric) was purchased from Roche
Diagnostics GmbH (Penzberg, Germany). The human
promyelocytic leukemia cell line HL60 was purchased
from RIKEN Cell Bank (Tsukuba, Japan) and cultured in
RPMI (Roswell Park Memorial Institute) 1640 medium
(Invitrogen Corp., Carlsbad, CA USA) containing 10 %
fetal calf serum (JRH Biosciences Inc., Lenexa, KS,
USA).
Cell proliferation
Cell proliferation was investigated by measuring 5-
bromo-2-deoxyuridine (BrdU) incorporation during DNA
synthesis as described by a previous study8). HL60 cells
(1.2 × 104 cells) in 100 µl of RPMI 1640 medium con-
taining chemical(s) were placed in each well of a 96-well
microtiter plate for BrdU incorporation, and cell prolifera-
tion was assessed after 24 h of culture.
Determination of cytokine levels
HL60 cells (1 × 105 cells) in 0.5 ml of RPMI 1640
medium containing chemical(s) were cultured in each well
of a 24-well culture plate for 24 h and then the media
were collected. To achieve the maximum IL-8 concentra-
tion, HL60 cells were treated with 1 μg/ml of nivalenol,
because IL-8 secretion was peaked at this concentration in
HL60 cells2). The morphology of the cells2) and the extent
of DNA laddering3) suggested that the cells were still vi-
able in 1 μg/ml of nivalenol. The collected media were
centrifuged at 5,000 × g for 5 min to obtain the superna-
tants and to remove cells and cell debris. Further, the su-
pernatants were analyzed to determine the levels of IL-8
and MCP-1 using Quantikine Human IL-8 Immunoassay
kit (R&D Systems, Inc., Minneapolis, MN, USA) and
Quantikine Human CCL2/MCP-1 Immunoassay kit (R&D
Systems, Inc., Minneapolis, MN, USA), respectively, ac-
cording to the manufacturer’s recommended procedures.
Statistics
Data were expressed in terms of mean ± standard
deviation. Intergroup differences were analyzed by
Tukey’s test. A P value less than 0.05 was considered to
be statistically significant.
Results and Discussion
To our knowledge, there are no studies that report the
role of RyRs in nivalenol toxicity. Here, therefore, we ex-
amined the importance of RyR1 in the exertion of niva-
lenol toxicity in HL60 cells.
We investigated the effects of the RyR1-specific in-
hibitor dantrolene7) on cell proliferation. In our hands,
cell proliferation was the most sensitive measure of cell
viability2). The 50 % inhibitory concentration of nivalenol
was about 0.16 μg/ml2); therefore, we performed our ex-
periments with 0.3 μg/ml of nivalenol. We chose the low-
est effective concentration of dantrolene—40 μM—as the
final concentration. As we reported previously2), nivalenol
alone markedly hindered cell proliferation (10.1 % of vehi
cle-treated control value; Table 1). On the other hand,
treatment with dantrolene alone led to moderate inhibition
of cell proliferation (76.5 %; Table 1). We found that re-
gardless of the presence of dantrolene, the values in niva
lenol-treated samples were almost the same (10.1 % ver-
sus 9.9 %; Table 1). If RyR1 is indifferent to the niva-
lenol signal transduction pathway(s), the effects of niva-
lenol and dantrolene should be additive, therefore, our re-
sults suggest that RyR1 may play a role in the nivalenol-
associated retardation of cell proliferation in HL60 cells.
It has been reported that dantrolene inhibited cell prolif-
２
eration stimulated by leukotriene B49) and growth fac-
tors10). Conversely, this chemical antagonized morphine-
caused inhibition of cell proliferation11), thereby indicating
that the contribution of RyR1 to cell proliferation is Janus
-faced. Our results confirm the validity of this concept.
Nivalenol significantly elicited IL-8 secretion in HL
60 cells (319.6 % of the value in the vehicle-treated sam-
ples), alternatively, dantrolene alone did not alter IL-8 se-
cretion (98.2 %; Table 2). The secretion of IL-8 in cells
concomitantly treated with nivalenol and dantrolene was
much lower (256.2 %) than IL-8 secretion in cells treated
with nivalenol alone (319.6 %; Table 2). Thus, it is likely
that RyR1 is important for nivalenol-induced IL-8 secre-
tion. Hisatsune et al.12) and Goyal et al.13) reported that
dantrolene inhibited IL-8 secretion induced by vacuolating
cytotoxin A (VacA)12), a Helicobactor pylori-produced pro-
tein, and the IL-8 secretion induced by an adhesin pro-
duced by enteroaggregative Escherichia coli13), respec-
tively. Since our results are consistent with these results,
nivalenol might share signal transduction pathway(s) with
these proteins.
Nivalenol reduced MCP-1 secretion (60.0 % of the
value in the vehicle-treated samples; Table 3), which has
also been reported by previous study4). Similarly, dan-
trolene moderately reduced MCP-1 secretion (85.0 %; Ta-
ble 3). MCP-1 secretion in cells concomitantly treated
with nivalenol and dantrolene (65.7 %) was higher than
that in the cells treated with nivalenol alone (60.0 %), in-
dicating that dantrolene alleviates the effect of nivalenol
on HL60 cells. To our knowledge, the relationship be-
tween RyR1 and MCP-1 secretion has not been previously
reported, and this is the first study that reports this asso-
ciation.
We showed that RyR1 plays a role in nivalenol-in
duced toxicity in HL60 cells. Because RyRs activation, in
general, is considered to be triggered by an increase in the
concentration of intracellular calcium ion6), further studies
are required to elucidate the detailed mechanism of niva
lenol-induced activation of RyR1.
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リアノジン受容体の阻害剤ダントロレンはHL６０細胞における
ニバレノール誘導性の細胞毒性を軽減する
長嶋 等，中川 博之，久城 真代
独立行政法人農業・食品産業技術総合研究機構 食品総合研究所
要 約
ニバレノール（NIV）の毒性発現機構を解明するた
めに，細胞内カルシウムチャンネルであるリアノジン
受容体１（RyR1）の HL６０細胞における NIV誘導性
の細胞毒性への関与を，RyR1特異的阻害剤のダント
ロレンを用いて検討した。それぞれのアッセイは薬剤
の２４時間処理後に行った。NIVは顕著に細胞増殖を
阻害したが，ダントロレンによる阻害は穏やかであっ
た。もし RyR1が NIVのシグナル伝達経路に関係ない
のであれば，ダントロレンが NIVによる阻害作用を
増強することが期待される。ダントロレンは NIVの
作用を増強しなかったことから，RyR1は NIVによる
細胞増殖阻害に何らかの役割を果たしているのかもし
れない。NIVは顕著にインターロイキン（IL）-８の分泌
を誘導したが，ダントロレンは IL-８分泌量を変化さ
せなかった。ダントロレンは NIVの影響を十分に減
じたので，RyR1が NIV誘導性の IL-８分泌に重要であ
ると考えられた。NIVとダントロレンは単球走化性
タンパク質（MCP）-１の分泌を減少させたが，ダントロ
レンによる減少は穏やかだった。ダントロレンは明ら
かに NIVの作用を和らげたので，RyR1は NIVによる
MCP-１分泌阻害に関与していると考えられた。以上の
結果から，NIVの HL６０細胞に対する細胞毒性の発現
には RyR1が関与していると考えられた。
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